Barclays’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.11M | Sell |
|
|||||
|
2025
Q2 | $1.06M | Buy |
|
|||||
|
2025
Q1 | $771K | Sell |
|
|||||
|
2024
Q4 | $854K | Buy |
|
|||||
|
2024
Q3 | $722K | Buy |
|
|||||
|
2024
Q2 | $382K | Sell |
|
|||||
|
2024
Q1 | $516K | Sell |
|
|||||
|
2023
Q4 | $725K | Buy |
|
|||||
|
2023
Q3 | $554K | Buy |
|
|||||
|
2023
Q2 | $824K | Buy |
|
|||||
|
2023
Q1 | $682K | Buy |
|
|||||
|
2022
Q4 | $716K | Sell |
|
|||||
|
2022
Q3 | $981K | Buy |
|
|||||
|
2022
Q2 | $199K | Sell |
|
|||||
|
2022
Q1 | $507K | Sell |
|
|||||
|
2021
Q4 | $1.12M | Buy |
|
|||||
|
2021
Q3 | $974K | Buy |
|
|||||
|
2021
Q2 | $729K | Sell |
|
|||||
|
2021
Q1 | $1.47M | Buy |
|
|||||
|
2020
Q4 | $1.08M | Sell |
|
|||||
|
2020
Q3 | $1.03M | Buy |
|
|||||
|
2020
Q2 | $1.11M | Buy |
|
|||||
|
2020
Q1 | $760K | Sell |
|
|||||
|
2019
Q4 | $1.47M | Buy |
|
|||||
|
2019
Q3 | $1M | Sell |
|
|||||
|
2019
Q2 | $1.28M | Buy |
|
|||||
|
2019
Q1 | $1.24M | Buy |
|
|||||
|
2018
Q4 | $620K | Sell |
|
|||||
|
2018
Q3 | $1.5M | Buy |
|
|||||
|
2018
Q2 | $126K | Sell |
|
|||||
|
2018
Q1 | $417K | Buy |
|
|||||
|
2017
Q4 | $195K | Sell |
|
|||||
|
2017
Q3 | $891K | Buy |
|
|||||
|
2017
Q2 | $318K | Sell |
|
|||||
|
2017
Q1 | $559K | Buy |
|
|||||
|
2016
Q4 | $267K | Sell |
|
|||||
|
2016
Q3 | $401K | Buy |
|
|||||
|
2016
Q2 | $95K | Buy |
|
|||||
|
2016
Q1 | $36K | Sell |
|
|||||
|
2015
Q4 | $84K | Sell |
|
|||||
|
2015
Q3 | $282K | Sell |
|
|||||
|
2015
Q2 | $310K | Buy |
|
|||||
|
2015
Q1 | $154K | Sell |
|
|||||
|
2014
Q4 | $3.31M | Buy |
|
|||||
|
2014
Q3 | $23K | Sell |
|
|||||
|
2014
Q2 | $526K | Buy |
|
|||||
|
2014
Q1 | $461K | Sell |
|
|||||
|
2013
Q4 | $3.94M | Buy |
|
|||||
|
2013
Q3 | $442K | Buy |
|
|||||
|
2013
Q2 | $76K | Buy |
|